2012
DOI: 10.1016/j.cvfa.2011.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Evidence-Based Effectiveness of Vaccination Against Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in Feedlot Cattle for Mitigating the Incidence and Effect of Bovine Respiratory Disease Complex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
49
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(50 citation statements)
references
References 17 publications
1
49
0
Order By: Relevance
“…In feedlots, BRD is primarily managed through administration of vaccines and antimicrobial agents. Vaccination is typically for viruses and to a lesser extent, for bacteria such as M. haemolytica , although efficacy has been variable (Larson and Step, 2012). In contrast, antimicrobial agents such as ceftiofur, florfenicol, tulathromycin, and tilmicosin have been shown to reduce morbidity when used metaphylactically on high-risk cattle entering feedlots (Taylor et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…In feedlots, BRD is primarily managed through administration of vaccines and antimicrobial agents. Vaccination is typically for viruses and to a lesser extent, for bacteria such as M. haemolytica , although efficacy has been variable (Larson and Step, 2012). In contrast, antimicrobial agents such as ceftiofur, florfenicol, tulathromycin, and tilmicosin have been shown to reduce morbidity when used metaphylactically on high-risk cattle entering feedlots (Taylor et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…To date, vaccination has shown inconsistent efficacy against M. haemolytica, P. multocida, and H. somni infection in feedlot cattle (7). As a result, antimicrobials are often the primary management practice used to reduce the incidence of BRD in large feedlots.…”
mentioning
confidence: 99%
“…Immunization with the IbpA DR2 subunit from H. somni was demonstrated to partially protect against bacterial infection in a natural host (16,30). However, further studies will be necessary to determine the immunogenic properties of the different virulence factors involved in H. somni infection, since the evidence for protection against pneumonia by current vaccines remains controversial (29,48).…”
Section: Discussionmentioning
confidence: 99%
“…These immune evasive strategies probably contribute to the failure of currently available vaccines to provide complete protection against these pathogens (24,29,48). Consequently, the combination of multiple antigens in an enriched vaccine may provide more effective protection.…”
mentioning
confidence: 99%